| Business Type | Manufacturer, Exporter, Supplier |
| Country of Origin | Made In India |
| Application | Hospital |
| Form : | liquid |
| Click to view more | |
Product Details
Strength :
100mg
Brand name :
Ujvira
Packaging Type
Box
Manufacturer
Zydus
Ujvira 100mg Injection is a targeted therapy containing the active constituent trastuzumab emtansine. The U.S. Food and Drug Administration (FDA) approved trastuzumab emtansine on February 22, 2013, for treating patients with HER2-positive metastatic breast cancer who have previously received trastuzumab and chemotherapy.
Looking for "Ujvira 100mg Injection" ?
Piece
